Performance and Tolerability of a New Medical Device Gel, a Randomized, Open Label, Parallel-group, Multicentre Study

NCT03423784 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Tooth Disease

Interventions

DEVICE: HA BPX V3.3
OTHER: Dentinox-Gel N

Sponsor

Opera CRO, a TIGERMED Group Company